Immediate Impact

1 by Nobel laureates 23 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

ChatGPT: five priorities for research
2023 StandoutNature
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression
2023 Standout
5 intermediate papers

Works of Michael R. Liebowitz being referenced

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
2019 Standout
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
2010
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael R. Liebowitz 13844 13341 3917 4551 312 22.8k
Michael W. Otto 12024 10274 7651 4482 446 27.4k
Mark H. Pollack 9239 7889 4556 3054 382 19.1k
Daniel N. Klein 14434 9427 6450 4812 471 25.3k
Philip Spinhoven 13517 7307 6427 3510 436 25.2k
Y. Lecrubier 10365 6872 7817 4592 178 25.9k
William G. Iacono 14503 7242 6283 5959 586 28.6k
Jack M. Gorman 7268 8021 6065 5034 379 23.0k
Mária Kovács 15989 5670 5049 2125 188 23.8k
Karl Rickels 6788 5968 4812 2391 415 19.7k
Donald F. Klein 5644 5743 4403 3966 289 15.4k

All Works

Loading papers...

Rankless by CCL
2026